View in EDS HTML Full Text PDF Full Text

TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.

Saved in:

Bibliographic Details
Title:	TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.
Authors:	Liu, Jia¹ (AUTHOR), Wang, Yiming^2,3 (AUTHOR), Wei, Xiaoxia¹ (AUTHOR), Liu, Suyan² (AUTHOR), Hu, Congting¹ (AUTHOR), Peng, Pingping¹ (AUTHOR), Wu, Wenhua¹ (AUTHOR), Cai, Jiaqin¹ (AUTHOR) jiaqincai@163.com, Sun, Hong¹ (AUTHOR) sunhong7777@fjmu.edu.cn
Source:	Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p1871-1887. 17p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	22113428
DOI:	10.1007/s13402-025-01114-0